BioCentury | Mar 28, 2019
Financial News

Antidepressant developer ATAI raises $43M series B round

...drug discovery and development. It plans to use some of the funding for future acquisitions. Subversive Capital...
Items per page:
1 - 1 of 1
BioCentury | Mar 28, 2019
Financial News

Antidepressant developer ATAI raises $43M series B round

...drug discovery and development. It plans to use some of the funding for future acquisitions. Subversive Capital...
Items per page:
1 - 1 of 1